Kopin (NASDAQ:KOPN) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS

Key Points

• Earnings beat but fundamentals lag: Kopin reported $0.04 EPS vs. a consensus of -$0.02 (beating by $0.06), yet revenue missed at $8.37M vs. $12.98M and the company remains unprofitable with a -13.81% net margin and -30.97% ROE.
• Shares and analyst view: the stock climbed to $2.83 (market cap ≈ $515.6M) and carries an average analyst rating of "Moderate Buy" with a $4.69 target, despite several recent downgrades.
• Institutional activity: major investors increased holdings in the quarter — notably State Street raised its stake by 224% to about 11.12M shares — and institutions now own ~30.96% of the company.

Kopin (NASDAQ:KOPN - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.06, FiscalAI reports. Kopin had a negative net margin of 13.81% and a negative return on equity of 30.97%. The company had revenue of $8.37 million for the quarter, compared to analyst estimates of $12.98 million.

Kopin Price Performance

Kopin stock traded up $0.17 during mid-day trading on Monday, hitting $2.83. The company's stock had a trading volume of 1,933,484 shares, compared to its average volume of 2,996,706. The firm's 50 day moving average is $2.28 and its 200 day moving average is $2.64. The company has a market cap of $515.59 million, a PE ratio of -70.63 and a beta of 2.73. Kopin has a 52-week low of $0.81 and a 52-week high of $4.16.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Weiss Ratings restated a "sell (e+)" rating on shares of Kopin in a research report on Thursday, January 22nd. Wall Street Zen downgraded Kopin from a "hold" rating to a "sell" rating in a research note on Saturday, April 4th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $4.69.

Institutional Investors Weigh In On Kopin

Large investors have recently added to or reduced their stakes in the stock. State Street Corp lifted its position in Kopin by 224.0% during the 4th quarter. State Street Corp now owns 11,119,885 shares of the company's stock worth $26,021,000 after acquiring an additional 7,687,358 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Kopin by 11.2% in the third quarter. Vanguard Group Inc. now owns 9,376,264 shares of the company's stock worth $22,784,000 after purchasing an additional 945,662 shares during the period. Geode Capital Management LLC lifted its position in shares of Kopin by 14.5% during the 4th quarter. Geode Capital Management LLC now owns 4,306,623 shares of the company's stock worth $10,080,000 after purchasing an additional 544,189 shares during the last quarter. Invesco Ltd. lifted its position in shares of Kopin by 538.5% during the 4th quarter. Invesco Ltd. now owns 704,951 shares of the company's stock worth $1,650,000 after purchasing an additional 594,546 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Kopin by 9.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 519,979 shares of the company's stock valued at $1,217,000 after purchasing an additional 44,595 shares during the period. Institutional investors own 30.96% of the company's stock.

Kopin Company Profile

Kopin Corporation NASDAQ: KOPN is a technology company specializing in the development and manufacture of high-resolution microdisplays and optical components for wearable electronics. Headquartered in Westborough, Massachusetts, Kopin designs both liquid crystal on silicon (LCOS) and organic light-emitting diode (OLED) microdisplays, as well as complete display engines and optical modules tailored for use in augmented reality (AR), virtual reality (VR), industrial, medical, and defense applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.